|
SKA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.679700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.383600E-02 |
| Normal-vs-Stage2 |
1.583770E-01 |
| Normal-vs-Stage3 |
3.717000E-01 |
| Normal-vs-Stage4 |
4.811800E-01 |
| Stage1-vs-Stage2 |
7.316200E-01 |
| Stage1-vs-Stage3 |
4.478800E-01 |
| Stage1-vs-Stage4 |
7.535900E-02 |
| Stage2-vs-Stage3 |
4.089600E-01 |
| Stage2-vs-Stage4 |
1.207410E-01 |
| Stage3-vs-Stage4 |
2.889400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.398100E-02 |
| Normal-vs-AfricanAmerican |
2.372000E-01 |
| Normal-vs-Asian |
6.747700E-02 |
| Caucasian-vs-AfricanAmerican |
6.829400E-01 |
| Caucasian-vs-Asian |
3.643600E-02 |
| AfricanAmerican-vs-Asian |
3.825500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.707600E-02 |
| Normal-vs-Female |
9.007000E-01 |
| Male-vs-Female |
2.474100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.811960E-01 |
| Normal-vs-Extreme_Weight |
1.475000E-01 |
| Normal-vs-Obese |
2.233600E-01 |
| Normal-vs-Extreme_Obese |
7.944700E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.011800E-01 |
| Normal_Weight-vs-Obese |
7.323000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.991800E-01 |
| Extreme_Weight-vs-Obese |
8.896200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.579990E-01 |
| Obese-vs-Extreme_Obese |
1.002170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.000400E-02 |
| Normal-vs-Age(41-60Yrs) |
7.060000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.879800E-03 |
| Normal-vs-Age(81-100Yrs) |
4.033800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.860500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.70339999999713E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.576100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.802500E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.204770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.770200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.032000E-01 |
| Normal-VS-Type2 PRCC |
5.578800E-04 |
| Normal-VS-KIRP CIMP |
2.419100E-03 |
| Normal-VS-Unclassified PRCC |
4.903400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.682500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.635420E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.467600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.08550000052799E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.060200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.844500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.512300E-02 |
| Normal-vs-N1 |
4.369400E-01 |
| Normal-vs-N2 |
4.729800E-01 |
| N0-vs-N1 |
1.323660E-02 |
| N0-vs-N2 |
1.267840E-01 |
| N1-vs-N2 |
8.367200E-01 |
|
|
